New Zealand markets close in 29 minutes

Oracle Corporation (ORCL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
77.35-0.05 (-0.06%)
At close: 04:03PM EDT
77.15 -0.20 (-0.26%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close77.40
Open76.27
Bid0.00 x 800
Ask0.00 x 800
Day's range76.00 - 77.40
52-week range63.76 - 106.34
Volume4,858,132
Avg. volume8,096,414
Market cap206.132B
Beta (5Y monthly)0.86
PE ratio (TTM)32.10
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.28 (1.65%)
Ex-dividend date11 Jul 2022
1y target estN/A
  • GlobeNewswire

    Digital Remedy’s Collaboration with Oracle Moat Sees Continued Success

    CTV leader outperforms industry benchmarks in mitigated invalid traffic and increased viewabilityNEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Digital Remedy, a leading advertising and marketing technology platform offering programmatic media solutions, including performance CTV, today announced continued success for its collaboration with Oracle Moat to combat invalid traffic and help ensure campaign viewability in CTV and over-the-top (OTT) environments. In 2020, Digital Remedy expanded its work

  • GlobeNewswire

    Verizon 5G Ultra Wideband Now Lit up at the Oracle Industry Lab

    DEERFIELD, Ill. and NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Verizon and Oracle are teaming to explore how Verizon 5G Ultra Wideband can transform industries including utilities, manufacturing, communications, construction and engineering. With Verizon 5G Ultra Wideband now lit up at the Oracle Industry Lab outside of Chicago, partners and customers can explore, create, and test 5G use cases that create opportunities and solve their most pressing industry challenges. These range from carbon

  • GlobeNewswire

    Tactile Medical Announces New Appointments to Board of Directors

    Appoints Valerie Asbury and Brent ShaferMINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the appointment of Valerie L. Asbury and D. Brent Shafer to the Company’s Board of Directors (“Board”), effective January 5, 2022. Ms. Asbury will serve as a member of both the Audit Commi